| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
|
Cancer Immunol Immunother
|
2008
|
6.55
|
|
2
|
Eliminating catheter-related bloodstream infections in the intensive care unit.
|
Crit Care Med
|
2004
|
5.47
|
|
3
|
Comparison of "B" readers' interpretations of chest radiographs for asbestos related changes.
|
Acad Radiol
|
2004
|
4.71
|
|
4
|
The accuracy of surrogate decision makers: a systematic review.
|
Arch Intern Med
|
2006
|
4.17
|
|
5
|
Development in infants with autism spectrum disorders: a prospective study.
|
J Child Psychol Psychiatry
|
2006
|
3.54
|
|
6
|
Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders.
|
Arch Gen Psychiatry
|
2007
|
3.29
|
|
7
|
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer.
|
J Clin Oncol
|
2007
|
3.23
|
|
8
|
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.
|
J Clin Oncol
|
2014
|
3.20
|
|
9
|
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.
|
Clin Cancer Res
|
2005
|
2.10
|
|
10
|
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.
|
Blood
|
2011
|
2.03
|
|
11
|
Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee.
|
Clin Cancer Res
|
2010
|
1.93
|
|
12
|
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast.
|
Carcinogenesis
|
2007
|
1.91
|
|
13
|
Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer.
|
Clin Cancer Res
|
2009
|
1.85
|
|
14
|
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
|
Blood
|
2008
|
1.81
|
|
15
|
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
|
J Urol
|
2007
|
1.75
|
|
16
|
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.
|
EMBO Mol Med
|
2012
|
1.68
|
|
17
|
Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
|
Sci Transl Med
|
2013
|
1.66
|
|
18
|
Response to joint attention in toddlers at risk for autism spectrum disorder: a prospective study.
|
J Autism Dev Disord
|
2007
|
1.65
|
|
19
|
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
|
Clin Cancer Res
|
2008
|
1.62
|
|
20
|
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.
|
Blood
|
2006
|
1.59
|
|
21
|
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
|
Clin Cancer Res
|
2006
|
1.58
|
|
22
|
Prevalence and determinants of physician bedside rationing: data from Europe.
|
J Gen Intern Med
|
2006
|
1.57
|
|
23
|
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer.
|
Chest
|
2011
|
1.54
|
|
24
|
ZEB1-responsive genes in non-small cell lung cancer.
|
Cancer Lett
|
2010
|
1.50
|
|
25
|
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.
|
Leuk Res
|
2008
|
1.43
|
|
26
|
Capromab pendetide scanning has a potential role in optimizing patient selection for salvage cryosurgical ablation of the prostate.
|
Urology
|
2010
|
1.43
|
|
27
|
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.
|
J Natl Cancer Inst
|
2007
|
1.41
|
|
28
|
Ductal access for prevention and therapy of mammary tumors.
|
Cancer Res
|
2006
|
1.38
|
|
29
|
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung.
|
Clin Cancer Res
|
2004
|
1.35
|
|
30
|
Does it pay to pay? A randomized trial of prepaid financial incentives and lottery incentives in surveys of nonphysician healthcare professionals.
|
Nurs Res
|
2005
|
1.32
|
|
31
|
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors.
|
J Clin Oncol
|
2008
|
1.30
|
|
32
|
Tamoxifen-stimulated growth of breast cancer due to p21 loss.
|
Proc Natl Acad Sci U S A
|
2007
|
1.22
|
|
33
|
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer.
|
Cancer Biol Ther
|
2006
|
1.19
|
|
34
|
A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.
|
PLoS One
|
2011
|
1.17
|
|
35
|
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.
|
Clin Cancer Res
|
2010
|
1.15
|
|
36
|
Pharmacologic and toxicologic evaluation of C. novyi-NT spores.
|
Toxicol Sci
|
2005
|
1.14
|
|
37
|
Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
|
Biol Blood Marrow Transplant
|
2006
|
1.12
|
|
38
|
Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers.
|
Nicotine Tob Res
|
2011
|
1.10
|
|
39
|
Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression.
|
Proc Natl Acad Sci U S A
|
2004
|
1.09
|
|
40
|
Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.
|
J Clin Endocrinol Metab
|
2012
|
1.08
|
|
41
|
Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status.
|
Cancer Causes Control
|
2009
|
1.08
|
|
42
|
Risks and benefits associated with novel phase 1 oncology trial designs.
|
Cancer
|
2007
|
1.07
|
|
43
|
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.
|
Cancer Biol Ther
|
2004
|
1.06
|
|
44
|
Survival in men with nonmetastatic prostate cancer treated with hormone therapy: a quantitative systematic review.
|
J Clin Oncol
|
2007
|
1.05
|
|
45
|
Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis.
|
Cancer Res
|
2008
|
1.01
|
|
46
|
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method.
|
Clin Trials
|
2012
|
1.01
|
|
47
|
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
|
Support Care Cancer
|
2010
|
1.00
|
|
48
|
Symptoms, supportive care needs, and function in cancer patients: how are they related?
|
Qual Life Res
|
2008
|
0.99
|
|
49
|
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
|
Biol Blood Marrow Transplant
|
2006
|
0.99
|
|
50
|
Effect of DNA methylation on identification of aggressive prostate cancer.
|
Urology
|
2008
|
0.98
|
|
51
|
Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading.
|
Stat Med
|
2011
|
0.98
|
|
52
|
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.
|
Cancer
|
2009
|
0.98
|
|
53
|
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy.
|
Urology
|
2007
|
0.97
|
|
54
|
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
|
Blood
|
2014
|
0.96
|
|
55
|
Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.
|
Gynecol Oncol
|
2007
|
0.96
|
|
56
|
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling.
|
Cancer Res
|
2006
|
0.94
|
|
57
|
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.
|
J Immunol
|
2012
|
0.94
|
|
58
|
Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.
|
Biol Blood Marrow Transplant
|
2005
|
0.94
|
|
59
|
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.
|
Hum Mol Genet
|
2005
|
0.94
|
|
60
|
High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.
|
Ann Epidemiol
|
2012
|
0.94
|
|
61
|
Assessing an intervention to improve clinical trial perceptions among predominately African-American communities in South Carolina.
|
Prog Community Health Partnersh
|
2012
|
0.94
|
|
62
|
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
|
Clin Cancer Res
|
2008
|
0.93
|
|
63
|
Adolescent nondaily smokers: favorable views of tobacco yet receptive to cessation.
|
Nicotine Tob Res
|
2009
|
0.93
|
|
64
|
Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer.
|
Mol Cancer Ther
|
2007
|
0.93
|
|
65
|
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response.
|
Clin Cancer Res
|
2011
|
0.91
|
|
66
|
Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes.
|
Jpn J Radiol
|
2010
|
0.91
|
|
67
|
Evaluation of a nutrition education intervention for women residents of Washington, DC, public housing communities.
|
Health Educ Res
|
2006
|
0.91
|
|
68
|
Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.91
|
|
69
|
Association between venous thromboembolism and perioperative allogeneic transfusion.
|
Arch Surg
|
2007
|
0.91
|
|
70
|
Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
|
Mov Disord
|
2009
|
0.91
|
|
71
|
Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition.
|
Cancer Res
|
2013
|
0.90
|
|
72
|
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
|
Haematologica
|
2012
|
0.90
|
|
73
|
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.
|
Cancer Prev Res (Phila)
|
2011
|
0.90
|
|
74
|
Modified test statistics by inter-voxel variance shrinkage with an application to f MRI.
|
Biostatistics
|
2008
|
0.90
|
|
75
|
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas.
|
J Neurooncol
|
2009
|
0.89
|
|
76
|
Concordance of cancer patients' function, symptoms, and supportive care needs.
|
Qual Life Res
|
2009
|
0.89
|
|
77
|
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina.
|
Ann Epidemiol
|
2009
|
0.89
|
|
78
|
Ethical conflict in nurse practitioners and physician assistants in managed care.
|
Nurs Res
|
2006
|
0.89
|
|
79
|
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
|
Biol Blood Marrow Transplant
|
2007
|
0.88
|
|
80
|
Dynamics of tissue shrinkage during ablative temperature exposures.
|
Physiol Meas
|
2013
|
0.87
|
|
81
|
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.
|
Breast Cancer Res Treat
|
2011
|
0.86
|
|
82
|
A simple two-gene prognostic model for adenocarcinoma of the lung.
|
J Thorac Cardiovasc Surg
|
2008
|
0.86
|
|
83
|
The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer.
|
Int J Oncol
|
2008
|
0.85
|
|
84
|
Vitamin D3 supplementation, low-risk prostate cancer, and health disparities.
|
J Steroid Biochem Mol Biol
|
2012
|
0.85
|
|
85
|
Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade.
|
Cancer Biol Ther
|
2011
|
0.85
|
|
86
|
Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism.
|
Surgery
|
2004
|
0.84
|
|
87
|
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.
|
Cancer Immunol Immunother
|
2015
|
0.84
|
|
88
|
Evaluating an intervention to increase cancer knowledge in racially diverse communities in South Carolina.
|
Patient Educ Couns
|
2010
|
0.84
|
|
89
|
Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.
|
Am J Clin Oncol
|
2014
|
0.84
|
|
90
|
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
|
J Clin Oncol
|
2009
|
0.84
|
|
91
|
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
|
Neoplasia
|
2012
|
0.83
|
|
92
|
The relationship of body size to participation and success in a fruits and vegetables intervention among low-income women.
|
J Community Health
|
2008
|
0.82
|
|
93
|
Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy.
|
Am J Surg
|
2009
|
0.81
|
|
94
|
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
|
Breast Cancer Res Treat
|
2013
|
0.81
|
|
95
|
Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
|
Head Neck
|
2009
|
0.81
|
|
96
|
Salvage Resection for Isolated Local and/or Regional Failure of Head/Neck Cancer Following Definitive Concurrent Chemoradiotherapy Case Series and Review of the Literature.
|
Mcgill J Med
|
2011
|
0.80
|
|
97
|
Cisplatin/Irinotecan versus carboplatin/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer.
|
Am J Clin Oncol
|
2010
|
0.80
|
|
98
|
25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.
|
Surgery
|
2005
|
0.79
|
|
99
|
Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.79
|
|
100
|
Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer.
|
BMC Cancer
|
2007
|
0.78
|
|
101
|
How should treatment decisions be made for incapacitated patients, and why?
|
PLoS Med
|
2007
|
0.78
|
|
102
|
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.
|
Pigment Cell Melanoma Res
|
2014
|
0.78
|
|
103
|
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer.
|
Laryngoscope
|
2010
|
0.77
|
|
104
|
Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
|
J Child Adolesc Psychopharmacol
|
2015
|
0.77
|
|
105
|
Incorporating scientific knowledge into phenotype development: penalized latent class regression.
|
Stat Med
|
2010
|
0.77
|
|
106
|
Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery.
|
Spine (Phila Pa 1976)
|
2009
|
0.77
|
|
107
|
Cigarette smoking and the risk of dying from tobacco-related malignancies by race.
|
Anticancer Res
|
2011
|
0.75
|
|
108
|
Cross-platform Comparison of Two Pancreatic Cancer Phenotypes.
|
Cancer Inform
|
2010
|
0.75
|
|
109
|
Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival.
|
J Med Imaging Radiat Oncol
|
2010
|
0.75
|
|
110
|
CD8, FoxP3, and CD45RO+ Lymphocytic Infiltrates in Type I and Type II Endometrial Cancers in African American and European American Females.
|
Int J Gynecol Pathol
|
2017
|
0.75
|
|
111
|
Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.
|
J Autism Dev Disord
|
2014
|
0.75
|
|
112
|
Reducing anti-DT IgG concentrations to improve the efficacy of a diphtheria fusion protein.
|
Anticancer Drugs
|
2008
|
0.75
|
|
113
|
Utilizing endobronchial ultrasound with fine-needle aspiration to obtain tissue for molecular analysis: a single-center experience.
|
J Bronchology Interv Pulmonol
|
2011
|
0.75
|